Stalybridge, United Kingdom

Remedios Hernandez-Perni


Average Co-Inventor Count = 13.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Remedios Hernandez-Perni: Innovator in Alzheimer's Disease Treatment

Introduction

Remedios Hernandez-Perni is a notable inventor based in Stalybridge, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Alzheimer's disease. With a total of two patents to his name, his work focuses on innovative compounds that have the potential to impact medical science.

Latest Patents

Hernandez-Perni's latest patents include "Triaryl compounds and derivatives thereof." This invention relates to compounds characterized by a specific general formula, which are utilized for the treatment of Alzheimer's disease and the modulation of γ-secretase activity. Another significant patent is "Biphenyl carboxylic acids and derivatives thereof," which also addresses compounds with a defined general formula aimed at treating Alzheimer's disease and modulating γ-secretase activity.

Career Highlights

Throughout his career, Hernandez-Perni has worked with reputable companies such as Cellzome Limited and Ortho-McNeil Pharmaceutical Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.

Collaborations

Hernandez-Perni has collaborated with notable colleagues, including Francis Wilson and Alison Reid. Their combined expertise has contributed to the advancement of research in their respective fields.

Conclusion

Remedios Hernandez-Perni is a distinguished inventor whose work in developing compounds for Alzheimer's treatment showcases his commitment to advancing medical science. His patents reflect a dedication to innovation that could lead to significant breakthroughs in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…